Skip to search.
 FTSE 100 Up 3.56%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
528.66 Down 6.81(1.27%) 20:23 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:535.47
Open:540.00
Bid:527.39 x 100
Ask:528.79 x 100
1y Target Est:617.48
Beta:1.04311
Earnings Date:2 Nov - 6 Nov (Est.)
Day's Range:526.75 - 547.51
52wk Range:320.06 - 605.93
Volume:520,381
Avg Vol (3m):753,251
Market Cap:55.86b
P/E (ttm):133.37
EPS (ttm):3.96
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for REGN at this time.

Comparison

Symbol% ChgMkt Cap
REGNDown 1.27%55.86b
AMGNDown 0.97%115.62b

Key Statistics

Forward P/E (1 yr):35.91
P/S (ttm):16.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :12.18
Quarterly EPS Est (Sep-15) :3.10
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback